News

Ultragenyx: 'Hold' The Best Strategy As Stock Tanks On Bone Disease Study Miss
Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
Ultragenyx Pharmaceutical Inc.: Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase ...
BP flags lower gas, oil price hit for second quarter
BP's second-quarter results will be hit by lower prices it received for its gas and oil, it said in a quarterly trading ...
Dividend Harvesting Portfolio Week 227: $22,700 Allocated, $2,385.24 In Projected Dividends
The Dividend Harvesting Portfolio hit new all-time highs in value, profitability, and forward income. Learn more about the ...
The Dollar's upside correction stalls
JPY: From the low on July 1 near JPY142.70 through yesterday's high of almost JPY147.20, the dollar appreciated by slightly ...
BPM Partners' Latest Performance Management Vendor Landscape Matrix Adds New Details, New Vendors, And Agentic AI Coverage
Edition Adds AI-generated Customer Feedback Summaries and Platform GraphicsSTAMFORD, Conn., July 10, 2025 (GLOBE NEWSWIRE) -- BP ...